Editorial: Usefulness of Anchor Based Methods for Determining Clinically Meaningful Change in MCI due to AD
- PMID: 36641604
- DOI: 10.14283/jpad.2022.104
Editorial: Usefulness of Anchor Based Methods for Determining Clinically Meaningful Change in MCI due to AD
Conflict of interest statement
SBH is owner and employee of Pentara Corporation and SPD is an employee of Pentara Corporation. Pentara performs statistical analyses for dozens of companies as a paid consultant in the Alzheimer’s disease space.
Comment on
-
Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease.J Prev Alzheimers Dis. 2023;10(1):9-18. doi: 10.14283/jpad.2022.102. J Prev Alzheimers Dis. 2023. PMID: 36641605 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical